NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

NWBO can and should clarify the journal situation and at least provide the maximum date by which publication will take place like “The forthcoming article has been approved and will be published before July 31, 2018 but due to commitments to the publication we can not elaborate further until after publication or further characterize the content.

If so much really does hinge on this article then the company should know by now when it will be published and if anything can pass the estimate in any letter to shareholders.

By management going on record, all NWBO investors will be confident that the article will come by a date certain and this would increase the chances of a Yes vote on the increase and since markets would be oblivious to anything short of the news itself, it would allow NWBO investors to be rewarded with a knowledge differential that would let them confidently average down.

This idea only works if the article is real and the failure of NWBO to take even this basic step to aid the nominal owners of the firm tells us that the article might be another white elephant like EAMS, HE, the “investigation” and the Swiss “Approval” that serves its purpose as a distracting sop to investors before being allowed to fade away before being replaced by the next supposed catalyst (catalyst being a word not even management apologists dare use in connection with NWBO anymore).